Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase 2 Randomized, Double-Blind, Placebo-Controlled, 14-Day Repeat, Oral, Dose Ranging Study to Assess the Safety, Pharmacokinetic and Pharmacodynamic Effects of SP-304 in Patients With Chronic Idiopathic Constipation

Next Previous
X
Search
Trial Profile

A Phase 2 Randomized, Double-Blind, Placebo-Controlled, 14-Day Repeat, Oral, Dose Ranging Study to Assess the Safety, Pharmacokinetic and Pharmacodynamic Effects of SP-304 in Patients With Chronic Idiopathic Constipation

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 06 Jan 2020

Price :

$35 *

Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Plecanatide (Primary)
  • Indications Constipation
  • Focus Adverse reactions
  • Sponsors Bausch Health Companies

    • Most Recent Events

    • 09 May 2013 Detailed positive findings will be presented at the 2013 Digestive Disease Week (DDW) and will be published in 2013, according to a Synergy Pharmaceuticals Inc media release.
    • 05 Nov 2010 According to a Synergy Pharmaceuticals media release the trial status changed from recruiting to completed.
    • 07 Oct 2010 Results will be presented at the American College of Gastroenterology Annual Scientific meeting (Poster Number P762), according to a Synergy Pharmaceuticals media release.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top